Jerusalem Pharmaceuticals Co. Ltd. (PEX:JPH)
Palestine · Delayed Price · Currency is JOD · Price in USD 3.750
+0.160 (4.46%)
At close: Jul 28, 2026
Jerusalem Pharmaceuticals Ratios and Metrics
Market cap in millions JOD. Fiscal year is January - December.
Millions JOD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 96 | 59 | 49 | 49 | 42 | 36 | |
Market Cap Growth | 85.19% | 20.04% | 0.69% | 15.82% | 16.13% | 2.15% |
Enterprise Value | 90 | 53 | 43 | 41 | 39 | 37 |
Last Close Price | 2.66 | 1.59 | 1.30 | 1.25 | 1.04 | 0.86 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 13.21 | 8.13 | 13.68 | 9.83 | 8.23 | 7.72 |
PS Ratio | 2.69 | 1.69 | 1.73 | 1.73 | 1.28 | 1.10 |
PB Ratio | 1.49 | 0.94 | 0.96 | 0.99 | 0.91 | 0.74 |
P/TBV Ratio | 1.56 | 0.98 | 1.00 | 1.03 | 0.94 | 0.80 |
P/FCF Ratio | - | 51.39 | 6.94 | 8.72 | 3.62 | 13.20 |
P/OCF Ratio | - | 22.87 | 5.87 | 7.44 | 3.47 | 8.42 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 2.53 | 1.51 | 1.52 | 1.47 | 1.18 | 1.12 |
EV/EBITDA Ratio | 8.32 | 5.15 | 7.64 | 5.73 | 5.19 | 5.20 |
EV/EBIT Ratio | 9.48 | 5.77 | 9.05 | 6.49 | 6.20 | 6.48 |
EV/FCF Ratio | - | 45.96 | 6.10 | 7.44 | 3.35 | 13.40 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.03 | 0.02 | 0.02 | 0.04 | 0.03 | 0.04 |
Debt / EBITDA Ratio | 0.15 | 0.09 | 0.18 | 0.23 | 0.20 | 0.25 |
Debt / FCF Ratio | - | 0.82 | 0.15 | 0.32 | 0.13 | 0.68 |
Net Debt / Equity Ratio | -0.10 | -0.12 | -0.14 | -0.06 | -0.09 | -0.04 |
Net Debt / EBITDA Ratio | -0.62 | -0.76 | -1.29 | -0.41 | -0.53 | -0.29 |
Net Debt / FCF Ratio | 2.76 | -6.76 | -1.03 | -0.53 | -0.34 | -0.74 |
Asset Turnover | 0.48 | 0.48 | 0.45 | 0.47 | 0.54 | 0.56 |
Inventory Turnover | 1.95 | 1.97 | 2.10 | 1.72 | 1.79 | 1.61 |
Quick Ratio | 2.55 | 2.57 | 3.33 | 2.97 | 2.88 | 2.80 |
Current Ratio | 3.42 | 3.41 | 4.29 | 4.11 | 3.86 | 4.25 |
Return on Equity (ROE) | 12.59% | 12.84% | 7.21% | 10.45% | 10.77% | 9.55% |
Return on Assets (ROA) | 8.02% | 7.88% | 4.77% | 6.60% | 6.45% | 6.06% |
Return on Invested Capital (ROIC) | 13.40% | 14.81% | 8.13% | 11.48% | 11.22% | 10.07% |
Return on Capital Employed (ROCE) | 13.70% | 13.50% | 8.70% | 12.10% | 12.60% | 10.80% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 7.57% | 12.30% | 7.31% | 10.17% | 12.15% | 12.95% |
FCF Yield | -2.49% | 1.95% | 14.42% | 11.46% | 27.64% | 7.58% |
Dividend Yield | 2.00% | 3.34% | 2.19% | 2.83% | 5.10% | 4.92% |
Payout Ratio | 13.43% | 13.59% | 33.52% | 36.63% | 29.90% | 20.25% |
Total Shareholder Return | 2.00% | 3.34% | 2.19% | 2.83% | 5.10% | 4.92% |